FDA Signals Unclear Clinical Benefits Of Ardelyx's Kidney Disease Candidate

By: via Benzinga
The FDA's Cardiovascular and Renal Drugs Advisory Committee isscheduled to meetWednesday, November 16, to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.